

share
Volociximab CAS NO 558480-40-3
Unit Price:
CAS No.:558480-40-3
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Volociximab is a high-purity, research-grade monoclonal antibody targeting α5β1 integrin. This compound is critical for advanced biomedical research and development, particularly in the study of angiogenesis and related therapeutic pathways. It is primarily utilized by pharmaceutical R&D teams, academic research institutions, and biotechnology companies engaged in oncology and ophthalmology drug discovery.
Application
- Biomedical Research: A key reagent for in vitro and in vivo studies investigating the role of α5β1 integrin in tumor angiogenesis and metastasis.
- Therapeutic Development: Serves as a reference standard and a lead candidate in the development of anti-angiogenic and anti-cancer biologics.
- Mechanistic Studies: Used to block α5β1 integrin function to elucidate signaling pathways in cell adhesion, migration, and survival.
- Preclinical Evaluation: Essential for pharmacokinetic (PK), pharmacodynamic (PD), and efficacy studies in animal models of cancer and eye diseases.
- Assay Development: Employed as a critical component in the development and validation of cell-based and biochemical assays for drug screening.
- Quality Control Reference: Acts as a purity and activity reference standard for the quality control of related biopharmaceutical products.
Basic Information
| Product Name | Volociximab |
| CAS No. | 558480-40-3 |
| Molecular Formula | Contact for details |
| Molecular Weight | Approx. 150 kDa (Monoclonal Antibody) |
| Synonyms | M200; Anti-Integrin α-5 β-1 Recombinant Antibody; Anti-α5β1 Integrin Monoclonal Antibody; Volociximab (USAN); Recombinant Humanized Monoclonal Antibody M200; Anti-Fibronectin Receptor Antibody |
| EINECS | Contact for details |
Quality Control
Our Volociximab is manufactured under strict quality systems to ensure batch-to-batch consistency and high biological activity. Each lot is rigorously tested for purity, identity, potency, and sterility. A comprehensive Certificate of Analysis (COA) detailing specifications such as purity by SEC-HPLC, endotoxin levels, binding affinity, and biological activity is provided with every shipment to support your regulatory and research requirements.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store lyophilized material at -20°C or below. Reconstituted solutions should be aliquoted and stored at -80°C to avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive).
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder |
| Identification (SEC-HPLC) | Corresponds to reference standard |
| Purity (SEC-HPLC) | ≥ 95% (Monomer) |
| Protein Content (UV Absorbance) | ≥ 1.0 mg/vial |
| Endotoxin | < 1.0 EU/mg |
| Biological Activity (Cell Binding) | Confirmed |
| Sterility (Membrane Filtration) | Sterile |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






